Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 445062
1. Hawkins CM, Richardson DW, Vokonas PS: Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. Circulation; 1983 Jun;67(6 Pt 2):I94-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
  • The results from the Beta-Blocker Heart Attack Trial for patients ages 60-69 years indicate a significant beneficial effect of propranolol and an overall reduction in mortality of 33%.
  • This beneficial effect appears to begin early and continues through 3 years of follow-up.
  • Given these results, and considering the large number of hospital-diagnosed myocardial infarctions that occur each year in persons older than 60 years of age, it appears that the use of propranolol, where not contraindicated, could delay mortality in a substantial number of older postinfarction patients.
  • [MeSH-major] Myocardial Infarction / mortality. Propranolol / therapeutic use
  • [MeSH-minor] Adult. Aged. Clinical Trials as Topic. Female. Follow-Up Studies. Heart Diseases / mortality. Humans. Male. Middle Aged. Random Allocation

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. PROPRANOLOL HYDROCHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 6342843.001).
  • [ISSN] 0009-7322
  • [Journal-full-title] Circulation
  • [ISO-abbreviation] Circulation
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 9Y8NXQ24VQ / Propranolol
  •  go-up   go-down


2. Oparil S, Davis BR, Cushman WC, Ford CE, Furberg CD, Habib GB, Haywood LJ, Margolis K, Probstfield JL, Whelton PK, Wright JT Jr, ALLHAT Collaborative Research Group: Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension; 2013 May;61(5):977-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.
  • To determine whether an angiotensin-converting enzyme inhibitor (lisinopril) or calcium channel blocker (amlodipine) is superior to a diuretic (chlorthalidone) in reducing cardiovascular disease incidence in sex subgroups, we carried out a prespecified subgroup analysis of 15 638 women and 17 719 men in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
  • The primary outcome was fatal coronary heart disease or nonfatal myocardial infarction.
  • Secondary outcomes included all-cause mortality, stroke, combined cardiovascular disease (coronary heart disease death, nonfatal myocardial infarction, stroke, angina, coronary revascularization, heart failure [HF], or peripheral vascular disease), and end-stage renal disease.
  • In-trial rates of HF, stroke, and combined cardiovascular disease were significantly higher for lisinopril compared with chlorthalidone, and rates of HF were significantly higher for amlodipine compared with chlorthalidone in both men and women.
  • For both women and men, rates were not lower in the amlodipine or lisinopril groups than in the chlorthalidone group for either the primary coronary heart disease outcome or any other cardiovascular disease outcome, and chlorthalidone-based treatment resulted in the lowest risk of HF.
  • [MeSH-major] Antihypertensive Agents / therapeutic use. Coronary Disease / mortality. Coronary Disease / prevention & control. Hypertension / drug therapy. Hypolipidemic Agents / therapeutic use. Myocardial Infarction / mortality. Myocardial Infarction / prevention & control. Sex Factors
  • [MeSH-minor] Aged. Aged, 80 and over. Amlodipine / therapeutic use. Calcium Channel Blockers / therapeutic use. Chlorthalidone / therapeutic use. Diuretics / therapeutic use. Female. Follow-Up Studies. Heart Failure / epidemiology. Heart Failure / mortality. Heart Failure / prevention & control. Humans. Incidence. Lisinopril / therapeutic use. Longitudinal Studies. Male. Middle Aged. Risk Factors. Stroke / epidemiology. Stroke / mortality. Stroke / prevention & control

  • MedlinePlus Health Information. consumer health - Blood Pressure Medicines.
  • MedlinePlus Health Information. consumer health - Heart Attack.
  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. CHLORTHALIDONE .
  • Hazardous Substances Data Bank. LISINOPRIL .
  • Hazardous Substances Data Bank. AMLODIPINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hypertension. 1995 Mar;25(3):305-13 [7875754.001]
  • [Cites] Clin J Am Soc Nephrol. 2012 Jun;7(6):989-1002 [22490878.001]
  • [Cites] Ann Intern Med. 1997 May 15;126(10):761-7 [9148648.001]
  • [Cites] Arch Intern Med. 2005 Jun 27;165(12):1401-9 [15983290.001]
  • [Cites] JAMA. 2005 Jul 27;294(4):466-72 [16046653.001]
  • [Cites] Circulation. 2006 May 9;113(18):2201-10 [16651474.001]
  • [Cites] J Hypertens. 2006 Nov;24(11):2163-8 [17053536.001]
  • [Cites] Hypertension. 2000 Nov;36(5):780-9 [11082143.001]
  • [Cites] Control Clin Trials. 2001 Feb;22(1):29-41 [11165421.001]
  • [Cites] S Afr Med J. 2001 Dec;91(12):1060-8 [11845604.001]
  • [Cites] Ann Intern Med. 2002 Sep 3;137(5 Part 1):313-20 [12204014.001]
  • [Cites] J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404 [12461301.001]
  • [Cites] JAMA. 2002 Dec 18;288(23):2981-97 [12479763.001]
  • [Cites] N Engl J Med. 2003 Feb 13;348(7):583-92 [12584366.001]
  • [Cites] JAMA. 2003 Apr 23-30;289(16):2073-82 [12709465.001]
  • [Cites] Hypertension. 2003 Sep;42(3):239-46 [12925554.001]
  • [Cites] J Clin Hypertens (Greenwich). 2004 Mar;6(3):116-25 [15010644.001]
  • [Cites] Lancet. 2004 Jun 19;363(9426):2022-31 [15207952.001]
  • [Cites] Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):99-118 [3538183.001]
  • [Cites] N Engl J Med. 1992 Sep 3;327(10):685-91 [1463530.001]
  • [Cites] Ann Epidemiol. 1993 Sep;3(5):555-62 [8167837.001]
  • [Cites] Lancet. 1999 Nov 20;354(9192):1751-6 [10577635.001]
  • [Cites] N Engl J Med. 2000 Jan 20;342(3):145-53 [10639539.001]
  • [Cites] JAMA. 2000 Apr 19;283(15):1967-75 [10789664.001]
  • [Cites] Cleve Clin J Med. 2000 Jun;67(6):429-33 [10860225.001]
  • [Cites] Lancet. 2000 Jul 29;356(9227):366-72 [10972368.001]
  • [Cites] Hypertension. 2008 Apr;51(4):1149-55 [18259013.001]
  • [Cites] Lancet. 2008 May 3;371(9623):1513-8 [18456100.001]
  • [Cites] Eur Heart J. 2008 Nov;29(21):2669-80 [18852183.001]
  • [Cites] Arch Intern Med. 2009 May 11;169(9):832-42 [19433694.001]
  • [Cites] Circulation. 2011 Oct 25;124(17):1811-8 [21969009.001]
  • [Cites] Circulation. 2012 Jan 3;125(1):e2-e220 [22179539.001]
  • [Cites] J Clin Hypertens (Greenwich). 2012 Jan;14(1):20-31 [22235820.001]
  • [Cites] Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):153-62 [22396585.001]
  • [Cites] Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60 [8722437.001]
  • (PMID = 23529173.001).
  • [ISSN] 1524-4563
  • [Journal-full-title] Hypertension (Dallas, Tex. : 1979)
  • [ISO-abbreviation] Hypertension
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00000542
  • [Grant] United States / NHLBI NIH HHS / HC / N01-HC-35130; United States / NCATS NIH HHS / TR / UL1 TR000439; United States / NHLBI NIH HHS / HL / N01HC35130; United States / NHLBI NIH HHS / HL / HHSN268201100036C; United States / PHS HHS / / HHSN268201100036C
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antihypertensive Agents; 0 / Calcium Channel Blockers; 0 / Diuretics; 0 / Hypolipidemic Agents; 1J444QC288 / Amlodipine; E7199S1YWR / Lisinopril; Q0MQD1073Q / Chlorthalidone
  • [Other-IDs] NLM/ NIHMS480708; NLM/ PMC4114223
  •  go-up   go-down


3. Lambert C, Vinson S, Shofer F, Brice J: The relationship between knowledge and risk for heart attack and stroke. J Stroke Cerebrovasc Dis; 2013 Oct;22(7):996-1001
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The relationship between knowledge and risk for heart attack and stroke.
  • BACKGROUND: Stroke and myocardial infarction (MI) represent 2 of the leading causes of death in the United States.
  • The early recognition of risk factors and event symptoms allows for the mitigation of disability or death.
  • We sought to compare subject knowledge of stroke and MI, assess subject risk for cardiovascular disease, and determine if an association exists between knowledge and risk.
  • METHODS: In this cross-sectional survey, adult, non-health care professionals were presented with a written knowledge test and risk assessment tool.
  • Subjects were classified into 3 categories of cardiovascular risk.
  • MI and stroke knowledge scores decreased as cardiovascular risk increased (85%, 79%, and 73% for ideal, low, and moderate/high risk groups, respectively; P < .001).
  • In addition, regardless of risk category, stroke knowledge scores were always lower than heart attack knowledge scores.
  • CONCLUSIONS: Knowledge about stroke and MI was modest, with knowledge of MI exceeding that of stroke at every level of risk.
  • Subjects with higher risk were less knowledgeable about the stroke signs, symptoms, and risk factors than those of MI.
  • [MeSH-major] Brain Ischemia / epidemiology. Health Knowledge, Attitudes, Practice. Myocardial Infarction / epidemiology. Stroke / epidemiology

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • MedlinePlus Health Information. consumer health - Ischemic Stroke.
  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.
  • (PMID = 22410654.001).
  • [ISSN] 1532-8511
  • [Journal-full-title] Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • [ISO-abbreviation] J Stroke Cerebrovasc Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Cerebrovascular accident / cerebrovascular disease / heart attack / knowledge / myocardial infarction / risk assessment / stroke
  •  go-up   go-down


Advertisement
4. New WHO pocket-charts will save lives by predicting heart attack and stroke. Cent Eur J Public Health; 2007 Dec;15(4):146
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] New WHO pocket-charts will save lives by predicting heart attack and stroke.
  • [MeSH-major] Myocardial Infarction / prevention & control. Practice Guidelines as Topic. Stroke / prevention & control

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18318046.001).
  • [ISSN] 1210-7778
  • [Journal-full-title] Central European journal of public health
  • [ISO-abbreviation] Cent. Eur. J. Public Health
  • [Language] eng
  • [Publication-type] News
  • [Publication-country] Czech Republic
  •  go-up   go-down


5. Goldstein S: The Beta-Blocker Heart Attack Trial in perspective. Cardiology; 1983;70(5):255-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Beta-Blocker Heart Attack Trial in perspective.
  • Recently completed Beta-Blocker Heart Attack Trial in which propranolol was administered to patients following an acute myocardial infarction resulted in a 26% decrease in total mortality and a 23% decrease in total coronary events in the propranolol-treated patients as compared to the placebo patients during the average follow-up of 25 months.
  • These results, coupled with the results of other trials using beta-adrenergic blocking agents including sotalol and timolol, strongly supports the beneficial effect of the routine administration of these beta blocking agents in the postmyocardial infarction patients.
  • [MeSH-major] Adrenergic beta-Antagonists / therapeutic use. Myocardial Infarction / complications. Propranolol / therapeutic use
  • [MeSH-minor] Adult. Aged. Arrhythmias, Cardiac / prevention & control. Clinical Trials as Topic. Death, Sudden / etiology. Double-Blind Method. Female. Heart Ventricles / physiopathology. Humans. Male. Middle Aged. Norway. Placebos / therapeutic use. Recurrence. Sotalol / therapeutic use. Timolol / therapeutic use

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. TIMOLOL .
  • Hazardous Substances Data Bank. PROPRANOLOL HYDROCHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 6141847.001).
  • [ISSN] 0008-6312
  • [Journal-full-title] Cardiology
  • [ISO-abbreviation] Cardiology
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] SWITZERLAND
  • [Chemical-registry-number] 0 / Adrenergic beta-Antagonists; 0 / Placebos; 817W3C6175 / Timolol; 9Y8NXQ24VQ / Propranolol; A6D97U294I / Sotalol
  •  go-up   go-down


6. Invisible thyroid problem ups your risk of heart attack. Mayo Clin Womens Healthsource; 2000 Jun;4(6):3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Invisible thyroid problem ups your risk of heart attack.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12944795.001).
  • [ISSN] 1091-0220
  • [Journal-full-title] Mayo Clinic women's healthsource
  • [ISO-abbreviation] Mayo Clin Womens Healthsource
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Rowley JM, Mounser P, Harrison EA, Skene AM, Hampton JR: Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J; 1992 Mar;67(3):255-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register.
  • OBJECTIVE: A register of patients with heart attacks in the Nottingham Health District has been maintained since 1973.
  • DESIGN: Data were collected prospectively on all patients transported to hospital in the Nottingham Health District with suspected myocardial infarction in the years 1982-84 and on patients treated at home during that time.
  • PATIENTS: 6712 patients admitted to hospital with suspected myocardial infarction and 1887 patients found dead on arrival at hospital.
  • Approximately 1500 patients in whom a myocardial infarction was suspected were treated at home, but only 125 were identified who had a definite or probable infarction.
  • Patients admitted more than nine hours after onset of symptoms with a diagnosis of definite or probable infarction had a poorer outcome than those admitted earlier (in-hospital mortality 22.4% v 13.1%).
  • The fatality rates of those admitted to a coronary care unit or to an ordinary medical ward are similar.
  • CONCLUSION: Although the introduction of thrombolytic therapy has brought with it an increased awareness of the need to minimise any delay in time to admission, it seems that in a predominantly urban area like Nottingham, patients with a suspected heart attack will continue to be admitted to hospital most quickly if an ambulance crew rather than a general practitioner is called.
  • [MeSH-major] Myocardial Infarction / therapy
  • [MeSH-minor] Coronary Care Units. Emergencies. England. Family Practice. Hospitalization. Humans. Registries. Time Factors. Transportation of Patients. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 1975 Nov 1;2(7940):833-8 [53328.001]
  • [Cites] Br Med J. 1976 Nov 13;2(6045):1169-72 [990827.001]
  • [Cites] Br Med J (Clin Res Ed). 1987 Feb 7;294(6568):352-4 [3101873.001]
  • [Cites] Br Heart J. 1972 Jan;34(1):67-80 [5059657.001]
  • [Cites] Br Med J (Clin Res Ed). 1982 Jun 12;284(6331):1741-6 [6805692.001]
  • [Cites] Br Med J. 1977 Jul 9;2(6079):81-3 [871804.001]
  • [Cites] Lancet. 1988 Sep 3;2(8610):525-30 [2900919.001]
  • [Cites] Br Heart J. 1973 Jun;35(6):616-22 [4712466.001]
  • [Cites] Br Med J. 1972 Jan 1;1(5791):34-6 [5008345.001]
  • [Cites] Lancet. 1978 Apr 22;1(8069):837-41 [76794.001]
  • (PMID = 1554544.001).
  • [ISSN] 0007-0769
  • [Journal-full-title] British heart journal
  • [ISO-abbreviation] Br Heart J
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] ENGLAND
  • [Other-IDs] NLM/ PMC1024802
  •  go-up   go-down


8. Williams RB: Cardiology Patient Page. Depression after heart attack: why should I be concerned about depression after a heart attack? Circulation; 2011 Jun 28;123(25):e639-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiology Patient Page. Depression after heart attack: why should I be concerned about depression after a heart attack?
  • [MeSH-major] Depression / etiology. Myocardial Infarction / complications. Myocardial Infarction / psychology

  • Genetic Alliance. consumer health - Depression.
  • MedlinePlus Health Information. consumer health - Depression.
  • MedlinePlus Health Information. consumer health - Heart Attack.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21709066.001).
  • [ISSN] 1524-4539
  • [Journal-full-title] Circulation
  • [ISO-abbreviation] Circulation
  • [Language] eng
  • [Publication-type] Journal Article; Patient Education Handout
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Serotonin Uptake Inhibitors
  •  go-up   go-down


9. Bahr RD: The early heart attack care strategy in the war against heart attack deaths utilizing the chest pain center approach in emergency departments. Md Med J; 1997;Suppl:9-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The early heart attack care strategy in the war against heart attack deaths utilizing the chest pain center approach in emergency departments.
  • The focus of this symposium is Maryland's heart attack problem.
  • The question is: Can the known evidence-based data on heart attacks be interpreted and applied in a systematic way that will unite efforts to reduce the significant heart attack deaths within the state?
  • Despite the medical advances in clot-dissolving therapies and minimally invasive surgeries, the acute prevention of heart attack death and damage has not been substantial.
  • Chest pain centers must function efficiently and cost effectively and bring about a community involvement that can significantly reduce heart attack deaths locally and, when combined with other hospitals, statewide.
  • [MeSH-major] Chest Pain / etiology. Emergency Service, Hospital / organization & administration. Myocardial Infarction / diagnosis. Myocardial Infarction / therapy

  • MedlinePlus Health Information. consumer health - Chest Pain.
  • MedlinePlus Health Information. consumer health - Heart Attack.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 9470337.001).
  • [ISSN] 0886-0572
  • [Journal-full-title] Maryland medical journal (Baltimore, Md. : 1985)
  • [ISO-abbreviation] Md Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


10. Medicare HMOs, FFS plans provide equal care following heart attack. Capitation Rates Data; 2001 Aug;6(8):92-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Medicare HMOs, FFS plans provide equal care following heart attack.
  • [MeSH-major] Fee-for-Service Plans / standards. Health Maintenance Organizations / standards. Medicare / standards. Myocardial Infarction / therapy. Quality of Health Care

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • MedlinePlus Health Information. consumer health - Medicare.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11526859.001).
  • [ISSN] 1090-1574
  • [Journal-full-title] Capitation rates & data
  • [ISO-abbreviation] Capitation Rates Data
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement